PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

February 1, 2029

Study Completion Date

February 1, 2029

Conditions
Pancreatic Cancer Non-resectable
Interventions
OTHER

collection of blood and tumor samples

"The study consists of the collection of a 25 ml blood sample:~* Before the start of treatment~* Approximately 2 months after the start of induction chemotherapy~* At the end of induction chemotherapy~* Prior to local treatment (radiotherapy, surgery)~* At the time of tumor progression~At the time of collection of tumor material:~* During the initial diagnostic biopsy~* On the operating room in case of surgery~* During a tumor biopsy in case of recurrence or progression (optional) and a questionnaire evaluating the patient's spontaneous physical activities."

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT05802485 - PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT | Biotech Hunter | Biotech Hunter